Chlorthalidone Tablets, 25 mg recall — Inventia Healthcare Ltd (Class II)

Inventia Healthcare Ltd is recorded by the U.S. Food and Drug Administration (FDA) as recalling Chlorthalidone Tablets, 25 mg — a Class II recall, initiated 2026-06-05 and posted to the FDA enforcement report on 2026-06-24, under recall number D-0610-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Failed Dissolution Specifications”. From the product description, the form is tablets, the strength given is 25 mg and it is marked Rx only. Distribution is recorded as “U.S. Nationwide” — Nationwide (US), with the recalling firm on record in India. It is the only recall number the FDA has filed under event ID 99136. 19 days separate the firm's initiation date from the FDA's report date on this record. It names Inventia Healthcare Limited, Additional Ambernath as the manufacturer. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0610-2026
FDA event ID 99136
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Inventia Healthcare Ltd
Recall initiated 2026-06-05
Reported by FDA 2026-06-24
Report lag 19 days from initiation to report
Distribution U.S. Nationwide. — Nationwide (US)
Firm location on record India
Product description (source) Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Reason reported by FDA

Failed Dissolution Specifications

3 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

5 identifying values matched by exact pattern in the 44-word product description above; each is a literal substring of it.

Product named Chlorthalidone Tablets
Form Tablets
Strength 25 mg
Marketing category Rx only
Manufactured by Inventia Healthcare Limited, Additional Ambernath
Distributed by Risiong Pharma Holdings, Inc.

Other Class II recalls with India on record

27 indexed records carry India as the recalling firm's country, against a dataset that is predominantly United States. These are the ones that also share this recall's FDA tier.

Recall recordRecall numberRecalling firmStrength / formReported
Methohexital Sodium for Injection, 500 mgD-0662-2026Onesource Specialty Pharma Ltd500 mg · for Injection2026-07-15
Pemetrexed for Injection 100mg/VialD-0671-2026Reliance Life Sciences Private Ltd100mg/Vial · for Injection2026-07-15
Pemetrexed for Injection 500mg/VialD-0672-2026Reliance Life Sciences Private Ltd500mg/Vial · for Injection2026-07-15
Bortezomib for Injection 3.5mg/VialD-0673-2026Reliance Life Sciences Private Ltd3.5mg/Vial · for Injection2026-07-15
Azacitidine for Injection 100mg/VialD-0674-2026Reliance Life Sciences Private Ltd100mg/Vial · for Injection2026-07-15
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KGD-0691-2026Shimoga Chemicals1 KG2026-07-15

Reported in the same month (2026-06)

74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Alyacen 7/7/7, 0.5mg/0.035mgD-0588-2026Glenmark Pharmaceuticals Inc., UsaClass II2026-06-24
VistaPharm, 25 GramsD-0589-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 50 GramsD-0590-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 25 GramsD-0591-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 50 GramsD-0592-2026Pai Holdings LLCClass II2026-06-24
Vasopressin 2 Units/2 mL in 0.9% Sodium ChlorideD-0593-2026Integradose Compounding Services LLCClass II2026-06-24
Aripiprazole Tablets USP, 30 mgD-0594-2026Ajanta Pharma Usa IncClass II2026-06-24
Buprenorphine HCl, 0.3 mg/mLD-0596-2026Par Health Usa, LLCClass II2026-06-24

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 2 nearest to 2026-06-24 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Pearson Quality Topical Anesthetic Gel (20% Benzocaine)D-0600-2026Keystone Industries20% · Gel2026-06-24
Quala Dental Products, 20 %D-0601-2026Keystone Industries20 % · Gel2026-06-24

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Inventia Healthcare Ltd (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0610-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0610-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-06-24
Ingested
2026-08-22
Record hash
19b857b9138a2b56

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.